Type-1 (CB1) and type-2 (CB2) cannabinoid receptors belong to the rhodopsin family of G protein-coupled receptors, and are activated by endogenous lipids termed "endocannabinoids". Recent reports have demonstrated that CB1R, unlike CB2R and other receptors and metabolic enzymes of endocannabinoids, functions in the context of lipid rafts, i.e. plasma membrane microdomains which may be important in modulating signal transduction. Here, we present novel data based on cell subfractionation, immunoprecipitation and confocal microscopy studies, that show that in C6 cells CB1R co-localizes almost entirely with caveolin-1. We also show that trafficking of CB1R in response to the raft disruptor methyl-beta-cyclodextrin (MCD) is superimposable on that of caveolin-1, and that MCD treatment increases the accessibility of CB1R to its specific antibodies. These findings may be relevant for the manifold CB1R-dependent activities of endocannabinoids, like the regulation of apoptosis and of neurodegenerative diseases.

Bari, M., Oddi, S., De Simone, C., Spagnolo, P., Gasperi, V., Battista, N., et al. (2008). Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells. NEUROPHARMACOLOGY, 54(1), 45-50 [10.1016/j.neuropharm.2007.06.030].

Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells

BARI, MONICA;GASPERI, VALERIA;CENTONZE, DIEGO;MACCARRONE, MAURO
2008-01-01

Abstract

Type-1 (CB1) and type-2 (CB2) cannabinoid receptors belong to the rhodopsin family of G protein-coupled receptors, and are activated by endogenous lipids termed "endocannabinoids". Recent reports have demonstrated that CB1R, unlike CB2R and other receptors and metabolic enzymes of endocannabinoids, functions in the context of lipid rafts, i.e. plasma membrane microdomains which may be important in modulating signal transduction. Here, we present novel data based on cell subfractionation, immunoprecipitation and confocal microscopy studies, that show that in C6 cells CB1R co-localizes almost entirely with caveolin-1. We also show that trafficking of CB1R in response to the raft disruptor methyl-beta-cyclodextrin (MCD) is superimposable on that of caveolin-1, and that MCD treatment increases the accessibility of CB1R to its specific antibodies. These findings may be relevant for the manifold CB1R-dependent activities of endocannabinoids, like the regulation of apoptosis and of neurodegenerative diseases.
gen-2008
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/26 - NEUROLOGIA
Settore BIO/10 - BIOCHIMICA
English
Con Impact Factor ISI
Immunoprecipitation; Caveolin 1; Cell Line, Tumor; Time Factors; beta-Cyclodextrins; Receptor, Cannabinoid, CB1; Cell Fractionation; Rats; Animals; Protein Transport; Glioma; Microscopy, Confocal
Bari, M., Oddi, S., De Simone, C., Spagnolo, P., Gasperi, V., Battista, N., et al. (2008). Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells. NEUROPHARMACOLOGY, 54(1), 45-50 [10.1016/j.neuropharm.2007.06.030].
Bari, M; Oddi, S; De Simone, C; Spagnolo, P; Gasperi, V; Battista, N; Centonze, D; Maccarrone, M
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/41470
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 45
  • ???jsp.display-item.citation.isi??? 42
social impact